These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10077394)

  • 1. N-terminal proatrial natriuretic peptide in angina pectoris: impact of revascularization by angioplasty.
    Klinge R; Jørgensen B; Thaulow E; Sirnes PA; Hall C
    Int J Cardiol; 1999 Jan; 68(1):1-8. PubMed ID: 10077394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
    Jørgensen B; Thaulow E;
    Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
    Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
    Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function.
    Otterstad JE; St John Sutton MG; Froeland GS; Holme I; Skjaerpe T; Hall C
    Eur Heart J; 2002 Jul; 23(13):1011-20. PubMed ID: 12093053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction.
    Kettunen RV; Leppäluoto J; Jounela A; Vuolteenaho O
    Am Heart J; 1994 Jun; 127(6):1449-55. PubMed ID: 8197967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rise and fall of B-type natriuretic peptide levels in patients with coronary artery disease and normal left ventricular function after cardiac revascularization.
    Palazzuoli A; Poldermans D; Capobianco S; Giannotti G; Iovine F; Campagna MS; Calabrò A; Bagaglia S; Nuti R
    Coron Artery Dis; 2006 Aug; 17(5):419-23. PubMed ID: 16845249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Power of plasma N-terminal proatrial natriuretic factor to determine haemodynamics in patients with cardiac disease: relation to serum creatinine.
    Dahle MG; Simonsen S; Hall C; Kjekshus JK
    Scand J Clin Lab Invest; 1998 Aug; 58(5):395-403. PubMed ID: 9819188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Vatne K; Hansen J; Webb J; Buller C; Goulet G; Erikssen J; Thaulow E
    J Am Coll Cardiol; 2000 Mar; 35(3):592-9. PubMed ID: 10716459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results and clinical implications of the CAPARES trial.
    Thaulow E; Jorgensen B
    Can J Cardiol; 2000 Jul; 16 Suppl D():8D-11D. PubMed ID: 10932030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk assessment in patients with unstable angina/non-ST-elevation myocardial infarction and normal N-terminal pro-brain natriuretic peptide levels by N-terminal pro-atrial natriuretic peptide.
    Jarai R; Iordanova N; Jarai R; Raffetseder A; Woloszczuk W; Gyöngyösi M; Geyer G; Wojta J; Huber K
    Eur Heart J; 2005 Feb; 26(3):250-6. PubMed ID: 15618049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of N-terminal proatrial natriuretic peptide plasma levels in a survey of adult male population from Southern Italy.
    Rubattu S; Barbato A; Marchitti S; Iacone R; Di Castro S; Evangelista A; Stanzione R; Ippolito R; Sciarretta S; Palmieri L; Volpe M; Strazzullo P;
    J Hypertens; 2010 Aug; 28(8):1638-45. PubMed ID: 20453667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides in patients with diastolic dysfunction due to idiopathic dilated cardiomyopathy.
    Fruhwald FM; Fahrleitner A; Watzinger N; Fruhwald S; Dobnig H; Schumacher M; Maier R; Zweiker R; Klein WW
    Eur Heart J; 1999 Oct; 20(19):1415-23. PubMed ID: 10487802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function.
    Andersson B; Hall C
    J Card Fail; 2000 Sep; 6(3):208-13. PubMed ID: 10997746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single-vessel coronary artery disease in a Veterans Affairs Cooperative randomized trial. Veterans Affairs ACME InvestigatorS.
    Folland ED; Hartigan PM; Parisi AF
    J Am Coll Cardiol; 1997 Jun; 29(7):1505-11. PubMed ID: 9180111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal proatrial natriuretic peptide predicts two-year remodelling in patients with acute transmural myocardial infarction.
    Hole T; Hall C; Skaerpe T
    Eur Heart J; 2004 Mar; 25(5):416-23. PubMed ID: 15033254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma N-terminal proatrial natriuretic factor can predict normal pulmonary capillary wedge pressure in cardiac transplant recipients.
    Dahle MG; Gullestad L; Simonsen S
    Scand Cardiovasc J; 2001 Dec; 35(6):367-71. PubMed ID: 11837515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of plasma atrial natriuretic peptide, N-terminal proatrial natriuretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function.
    Nishikimi T; Mori Y; Ishimura K; Tadokoro K; Yagi H; Yabe A; Horinaka S; Matsuoka H
    Am J Med; 2004 Apr; 116(8):517-23. PubMed ID: 15063812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases.
    Franz M; Woloszczuk W; Hörl WH
    Kidney Int; 2001 May; 59(5):1928-34. PubMed ID: 11318965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are plasma levels of atrial natriuretic peptide, N-terminal ProANP, and brain natriuretic peptide affected by the presence of coronary artery disease?
    Nishikimi T; Matsuoka H
    Circulation; 2004 Jun; 109(25):e331; author reply e331. PubMed ID: 15226240
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of coronary angioplasty and coronary artery bypass grafting outcomes in chronic dialysis patients.
    Rinehart AL; Herzog CA; Collins AJ; Flack JM; Ma JZ; Opsahl JA
    Am J Kidney Dis; 1995 Feb; 25(2):281-90. PubMed ID: 7847356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.